INCYTE CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
INCYTE CORPORATION (INCY) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $7.42 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-09.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2021-02-09
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2020 was $7.42M, a 42.30% increase from fiscal 2019.
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2019 was $5.21M, a 26.71% increase from fiscal 2018.
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2018 was $4.11M, a 35.22% decline from fiscal 2017.
- INCYTE CORPORATION effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2017 was $6.35M, a 208.15% increase from fiscal 2016.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2020-12-31 | $7.42M 10-K · filed 2021-02-09 |
| 2019-12-31 | $5.21M 10-K · filed 2021-02-09 |
| 2018-12-31 | $4.11M 10-K · filed 2021-02-09 |
| 2017-12-31 | $6.35M 10-K · filed 2020-02-13 |
| 2016-12-31 | $2.06M 10-K · filed 2019-02-14 |
| 2015-12-31 | $4.70M 10-K · filed 2018-02-15 |
| 2014-12-31 | $830.00K 10-K · filed 2017-02-14 |
| 2013-12-31 | $976.00K 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |